Diabetes Treatment: Oral and Non-Insulin Injectables

Question 1

Primary Organizations for Diabetic Clinical Guidelines

Answer 1

Question 2

Diabetic drug class options when weight gain is a concern

Answer 2

Question 3

Diabetic drug class options when cost is a concern

Answer 3

Question 4

Diabetic drug class options when hypoglycemia is a concern

Answer 4

Question 5

How often should medications be reviewed in people with diabetes?

Answer 5

Every 3 months if not in target

Question 6

Diabetes treatment class options for people with ASCVD

Answer 6

Question 7

Diabetes treatment class options for people with CKD

Answer 7

Question 8

Diabetes treatment class options for people with HF

Answer 8

Question 9

AACE Guidelines for A1c < 7.5%

Answer 9

Question 10

AACE Guidelines for A1c 7.5-9%

Answer 10

Question 11

AACE Guidelines for A1c > 9%

Answer 11

Question 12

Biguanides (1)
MOA, Dose, Max dose, Formulations

Answer 12

Question 13

Biguanides (1)
SE, Laboratory monitoring, Clinical considerations

Answer 13

Question 14

Sulfonylurease (3)
MOA, dose

Answer 14

Question 15

Sulfonylurease (3)
Formulation, SE, Laboratory monitoring, Clinical considerations

Answer 15

Question 16

Thiazolidinediones (2)
MOA, Dose, Formulation

Answer 16

Question 17

Thiazolidinediones (2)
SE, Laboratory monitoring, Clinical considerations

Answer 17